Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 168134, 9 pages
http://dx.doi.org/10.1155/2013/168134
Research Article

Intravenous Laser Blood Irradiation Increases Efficacy of Etanercept in Selected Subtypes of Juvenile Idiopathic Arthritis: An Innovative Clinical Research Approach

1“Grigore T. Popa” University of Medicine and Pharmacy, Faculty of Medicine, 16 Universitatii Street, 700115 Iasi, Romania
2Stronach Research Unit for Complementary and Integrative Laser Medicine, Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, and TCM Research Center Graz, Medical University Graz, Auenbruggerplatz 29, 8036 Graz, Austria
3Institute for Laser Therapy and Acupuncture, Sohnreystraße 6, 37697 Lauenförde, Germany
4Department of Medical Physics, “Alexandru Ioan Cuza” University, 11 Carol I Boulevard, 700506 Iasi, Romania
5Laser Clinic, 83 Arcu Street, 700135 Iasi, Romania
6St. Mary Emergency Hospital for Children, Second Pediatric Clinic, 62 Vasile Lupu Street, 700309 Iasi, Romania

Received 3 July 2013; Accepted 13 July 2013

Academic Editor: Lu Wang

Copyright © 2013 Dragos Andrei Chiran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ravelli and A. Martini, “Juvenile idiopathic arthritis,” The Lancet, vol. 369, no. 9563, pp. 767–778, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. E. Petty, T. R. Southwood, P. Manners et al., “International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001,” Journal of Rheumatology, vol. 31, no. 2, pp. 390–392, 2004. View at Google Scholar · View at Scopus
  3. P. J. Manners and C. Bower, “Worldwide prevalence of juvenile arthritis—why does it vary so much?” Journal of Rheumatology, vol. 29, no. 7, pp. 1520–1530, 2002. View at Google Scholar · View at Scopus
  4. K. Hayward and C. A. Wallace, “Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis,” Arthritis Research and Therapy, vol. 11, no. 1, article 216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Horneff, “Update on biologicals for treatment of juvenile idiopathic arthritis,” Expert Opinion on Biological Therapy, vol. 13, no. 3, pp. 361–376, 2013. View at Google Scholar
  6. J. Zeidler, T. Mittendorf, R. Müller, and J. von Kempis, “Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective,” Health Economics Review, vol. 2, article 20, no. 1, 2012. View at Google Scholar
  7. V. F. Schabert, C. Watson, S. R. Gandra, S. Goodman, K. M. Fox, and D. J. Harrison, “Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States,” Journal of Medical Economics, vol. 15, no. 2, pp. 264–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. European Medicines Agency, “European Public Assessment Report (EPAR) for Enbrel (Etanercept),” 2013, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000262/WC500027361.pdf.
  9. Order no. 220 emitted on 15 May 2007 by Romanian National Health Insurance House, “Approval of the protocol for practice, monitoring and reimbursement for medicines in cases of juvenile idiopathic arthritis for persons who are insured in the national social health insurance system” (Romanian), Monitorul Oficial al Romaniei, no. 255, part I, 2007.
  10. F. Aimbire, R. Albertini, M. T. T. Pacheco et al., “Low-level laser therapy induces dose-dependent reduction of TNFα levels in acute inflammation,” Photomedicine and Laser Surgery, vol. 24, no. 1, pp. 33–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Weber, “The intravenous laser blood irradiation. Introduction of a new therapy,” in Lasers in Medicine, Science and Praxis, Z. Simunovic, Ed., pp. 664–706, Zrinski Printery Publishing House, Cakovec, Croatia, 2009. View at Google Scholar
  12. E. H. Giannini, N. Ruperto, A. Ravelli, D. J. Lovell, D. T. Felson, and A. Martini, “Preliminary definition of improvement in juvenile arthritis,” Arthritis and Rheumatism, vol. 40, no. 7, pp. 1202–1209, 1997. View at Google Scholar · View at Scopus
  13. C. A. Wallace, N. Ruperto, and E. H. Giannini, “Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis,” Journal of Rheumatology, vol. 31, no. 11, pp. 2290–2294, 2004. View at Google Scholar · View at Scopus
  14. N. Ruperto, A. Ravelli, A. Pistorio et al., “Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology,” Clinical and Experimental Rheumatology, vol. 19, no. 4, pp. S1–S9, 2001. View at Google Scholar · View at Scopus
  15. E. H. Giannini, N. T. Ilowite, D. J. Lovell et al., “Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 60, no. 9, pp. 2794–2804, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Takei, D. Groh, B. Bernstein, B. Shaham, K. Gallagher, and A. Reiff, “Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis,” Journal of Rheumatology, vol. 28, no. 7, pp. 1677–1680, 2001. View at Google Scholar · View at Scopus
  17. F. De Benedetti, H. I. Brunner, N. Ruperto et al., “Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis,” The New England Journal of Medicine, vol. 367, no. 25, pp. 2385–2395, 2012. View at Google Scholar
  18. R. K. Saurenmann, A. V. Levin, J. B. Rose et al., “Tumour necrosis factor α inhibitors in the treatment of childhood uveitis,” Rheumatology, vol. 45, no. 8, pp. 982–989, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Tynjäaldie;, K. Kotaniemi, P. Lindahl et al., “Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis,” Rheumatology, vol. 47, no. 3, pp. 339–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Zulian, M. Balzarin, F. Falcini et al., “Abatacept for severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis-related uveitis,” Arthritis Care and Research, vol. 62, no. 6, pp. 821–825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Quartier, P. Taupin, F. Bourdeaut et al., “Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type,” Arthritis and Rheumatism, vol. 48, no. 4, pp. 1093–1101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Tracey, L. Klareskog, E. H. Sasso, J. G. Salfeld, and P. P. Tak, “Tumor necrosis factor antagonist mechanisms of action: a comprehensive review,” Pharmacology and Therapeutics, vol. 117, no. 2, pp. 244–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Thalayasingam and J. D. Isaacs, “Anti-TNF therapy,” Best Practice and Research, vol. 25, no. 4, pp. 549–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. W. He, G. Litscher, X. Y. Wang et al., “Intravenous laser blood irradiation, interstitial laser acupuncture, and electroacupuncture in an animal experimental setting: preliminary results from heart rate variability and electrocorticographic recordings,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 169249, 6 pages, 2013. View at Publisher · View at Google Scholar
  25. E. S. Boschi, C. E. Leite, V. C. Saciura et al., “Anti-inflammatory effects of low-level laser therapy (660 nm) in the early phase in carrageenan-induced pleurisy in rat,” Lasers in Surgery and Medicine, vol. 40, no. 7, pp. 500–508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Mesquita-Ferrari, M. D. Martins, J. A. Silva Jr. et al., “Effects of low-level laser therapy on expression of TNF-α and TGF-β in skeletal muscle during the repair process,” Lasers in Medical Science, vol. 26, no. 3, pp. 335–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Yamaura, M. Yao, I. Yaroslavsky, R. Cohen, M. Smotrich, and I. E. Kochevar, “Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes,” Lasers in Surgery and Medicine, vol. 41, no. 4, pp. 282–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Calmon-Hamaty, B. Combe, M. Hahne, and J. Morel, “Lymphotoxin α revisited: general features and implications in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 13, no. 4, article 232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Decoster, S. Cornelis, B. Vanhaesebroeck, and W. Fiers, “Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) α differentially modulate cellular sensitivity to TNF/LT-α cytotoxicity in L929 cells,” Journal of Cell Biology, vol. 143, no. 7, pp. 2057–2065, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. F. M. De Lima, A. B. Villaverde, R. Albertini et al., “Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines,” Lasers in Surgery and Medicine, vol. 43, no. 5, pp. 410–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Alves, P. T. de Carvalho, M. Parente et al., “Low-level laser therapy in different stages of rheumatoid arthritis: a histological study,” Lasers in Medical Science, vol. 28, no. 2, pp. 529–536, 2013. View at Google Scholar
  32. N. Schumm, “Laser blood irradiation for multiple sclerosis: a new treatment procedure with significant improvement of the quality of life,” KIM—Komplementare und Integrative Medizin, Artztezeitschrift fur Naturheilverfahren, vol. 49, no. 11-12, pp. 38–43, 2008. View at Google Scholar · View at Scopus
  33. S. F. Huang, Y. A. Tsai, S. B. Wu, Y. H. Wei, P. Y. Tsai, and T. Y. Chuang, “Effects of intravascular laser irradiation of blood in mitochondria dysfunction and oxidative stress in adults with chronic spinal cord injury,” Photomedicine and Laser Surgery, vol. 30, no. 10, pp. 579–586, 2012. View at Google Scholar
  34. F. Raggi and G. Vallesi, “Intravenous lasertherapy in sportsmedicine, a review of literature,” Photodiagnosis and Photodynamic Therapy, vol. 5, supplement 1, p. S13, 2008. View at Google Scholar
  35. A. Wirz-Ridolfi, “Comparison between intravenous and various types of transcutaneous laser blood irradiation,” The Internet Journal of Laserneedle Medicine, vol. 3, article 1, no. 1, 2013. View at Google Scholar